Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christence S. Teglbjaerg"'
Autor:
Roman S. Lorenc, Arne Hoiseth, Kurt Lippuner, Alfred H. Moffett, Michael A. Bolognese, Peter L. Lakatos, Cesar Libanati, Michael R. McClung, Christence S. Teglbjaerg, Jose R. Zanchetta, Maria Luisa Brandi, Andrea Wang
Publikováno v:
Journal of Clinical Densitometry. 16:147-153
Denosumab is an approved therapy for postmenopausal women with osteoporosis at high or increased risk for fracture. In the FREEDOM study, denosumab reduced fracture risk and increased bone mineral density (BMD). We report the spine and hip dual-energ
Autor:
S. Siddhanti, Henry G. Bone, E. Michael Lewiecki, Roland Chapurlat, Edward Czerwiński, Bente L. Langdahl, Alan Kivitz, Ugis Gruntmanis, Bo Abrahamsen, P.R. Ho, Michael R. McClung, Rachel B. Wagman, Y.-C. Yang, Faisal M. Mirza, Michael A. Bolognese, Östen Ljunggren, Christence S. Teglbjaerg, Jean-Yves Reginster, David L. Kendler, Eric S. Orwoll, Paul D. Miller
Publikováno v:
Langdahl, B L, Teglbjaerg, C S, Ho, P-R, Chapurlat, R, Czerwinski, E, Kendler, D L, Reginster, J-Y, Kivitz, A, Lewiecki, E M, Miller, P D, Bolognese, M A, McClung, M R, Bone, H G, Ljunggren, Ö, Abrahamsen, B, Gruntmanis, U, Yang, Y-C, Wagman, R B, Mirza, F, Siddhanti, S & Orwoll, E 2015, ' A 24-month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density : Results From the ADAMO Trial ', Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 4, pp. 1335–1342 . https://doi.org/10.1210/jc.2014-4079
Langdahl, B L, Teglbjaerg, C S, Ho, P-R, Chapurlat, R, Czerwinski, E, Kendler, D L, Reginster, J-Y, Kivitz, A, Lewiecki, E M, Miller, P D, Bolognese, M A, McClung, M R, Bone, H G, Ljunggren, Ö, Abrahamsen, B, Gruntmanis, U, Yang, Y-C, Wagman, R B, Mirza, F, Siddhanti, S & Orwoll, E 2015, ' A 24-month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density : Results From the ADAMO Trial ', Journal of Clinical Endocrinology and Metabolism, pp. jc20144079 . https://doi.org/10.1210/jc.2014-4079
Langdahl, B L, Teglbjaerg, C S, Ho, P-R, Chapurlat, R, Czerwinski, E, Kendler, D L, Reginster, J-Y, Kivitz, A, Lewiecki, E M, Miller, P D, Bolognese, M A, McClung, M R, Bone, H G, Ljunggren, Ö, Abrahamsen, B, Gruntmanis, U, Yang, Y-C, Wagman, R B, Mirza, F, Siddhanti, S & Orwoll, E 2015, ' A 24-month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density : Results From the ADAMO Trial ', Journal of Clinical Endocrinology and Metabolism, pp. jc20144079 . https://doi.org/10.1210/jc.2014-4079
Context: One in 4 men in the United States aged >50 years will have an osteoporosis-related fracture. Fewer data are available on osteoporosis treatment in men than in women. Objective: The purpose of this study was to evaluate denosumab therapy in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20da2c31e9f294348537f6c1eccbe1f2
https://acuresearchbank.acu.edu.au/item/8833y/a-24-month-study-evaluating-the-efficacy-and-safety-of-denosumab-for-the-treatment-of-men-with-low-bone-mineral-density-results-from-the-adamo-trial
https://acuresearchbank.acu.edu.au/item/8833y/a-24-month-study-evaluating-the-efficacy-and-safety-of-denosumab-for-the-treatment-of-men-with-low-bone-mineral-density-results-from-the-adamo-trial
Autor:
S. Siddhanti, Bente L. Langdahl, Ugis Gruntmanis, Michael A. Bolognese, Steven Boonen, Bo Abrahamsen, Roland Chapurlat, Christence S. Teglbjaerg, Michael R. McClung, Paul D. Miller, Y.-C. Yang, Eric S. Orwoll, Henry G. Bone, Alan Kivitz, Östen Ljunggren, Andreas Grauer, Edward Czerwiński, Rachel B. Wagman, E. Michael Lewiecki, David L. Kendler, Jean-Yves Reginster, J. W. Hall
Publikováno v:
Orwoll, E, Teglbjærg, C S, Langdahl, B L, Chapurlat, R, Czerwinski, E, Kendler, D L, Reginster, J-Y, Kivitz, A, Lewiecki, E M, Miller, P D, Bolognese, M A, McClung, M R, Bone, H G, Ljunggren, Ö, Abrahamsen, B, Gruntmanis, U, Yang, Y-C, Wagman, R B, Siddhanti, S, Grauer, A, Hall, J W & Boonen, S 2012, ' A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density ', Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 9, pp. 3161-9 . https://doi.org/10.1210/jc.2012-1569
Context: Men with low bone mineral density (BMD) were treated with denosumab. Objective: Our objective was to investigate the effects of denosumab compared with placebo in men with low BMD after 1 yr of treatment. Design, Subjects, and Intervention: